CGIM
ELV icon

Capital Group Investment Management’s Elevance Health ELV Stock Holding History

Capital Group Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,414
Closed -$733K – 156
2024
Q1 		$733K Sell
1,414
-6,124
-81% -$3.05M 0.13% 153
2023
Q4 		$3.55M Sell
7,538
-10,801
-59% -$4.99M 0.37% 91
2023
Q3 		$7.99M Sell
18,339
-12,930
-41% -$5.86M 0.52% 75
2023
Q2 		$13.9M Hold
31,269
– – 0.69% 64
2023
Q1 		$14.4M Sell
31,269
-17,319
-36% -$8.24M 0.77% 58
2022
Q4 		$24.9M Buy
+48,588
New +$24.7M 0.96% 42

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Group Investment Management's ELV Position: Q2 2024 in Review

Capital Group Investment Management sold out of Elevance Health (ELV) in Q2 2024, closing a stake of 1,414 shares — an estimated $733K sold.

Capital Group Investment Management first reported a position in ELV in Q4 2022 and held it in 6 quarters. The position peaked at $24.9M in Q4 2022. 1,705 funds tracked by Wall St. Rank hold ELV as of Q2 2024.

  • Capital Group Investment Management reported no remaining Elevance Health position as of Q2 2024 after selling out during the quarter.
  • Capital Group Investment Management sold 1,414 Elevance Health shares in Q2 2024, an estimated $733K.
  • Capital Group Investment Management first reported a position in Elevance Health in Q4 2022 and held it in 6 quarters.
  • Capital Group Investment Management's Elevance Health position peaked at $24.9M in Q4 2022.
  • 1,705 funds tracked by Wall St. Rank held Elevance Health as of Q2 2024.

Based on Capital Group Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.